Gestational Diabetes Market is segmented By Treatment (Insulin Therapy, Rapid-Acting Insulin, Short-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin, Oral ....
The major players operating in the gestational diabetes market include Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Medtronic plc, Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim GmbH, and Johnson & Johnson.
Gestational Diabetes Market